Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.32
-0.04 (-0.54%)
At close: Sep 11, 2026, 4:00 PM EDT
7.38
+0.06 (0.82%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $49.64 million as of September 11, 2026. Its market cap has decreased by -68.00% in one year.
Market Cap
49.64M
Enterprise Value
67.39M
1-Year Change
-68.00%
Ranking
Category
Stock Price
$7.32
ChartMarket Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $49.64M, a decrease of -98.03%. That is a compound annual growth rate of -51.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 49.64M | -33.45% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 57.29M |
| eXoZymes | 57.27M |
| Hyperion DeFi | 57.03M |
| ImageneBio | 56.87M |
| Apollomics | 54.64M |
| Impact BioMedical | 53.23M |
| Seres Therapeutics | 52.49M |
| Annovis Bio | 51.98M |